Скачать или смотреть Market Access Consulting Firm France | Justin Stindt

Navigating market access in France can be complex, but with Justin Stindt Consultants, you have a trusted partner to guide you. We provide strategic market access consulting for pharmaceutical, biotech, medtech, and digital health companies looking to succeed in France and across Europe.

🖱️ https://jstindt.com/france/

With 67 million people, France has a structured and regulated healthcare system, where the Haute Autorité de Santé (HAS) plays a key role in Health Technology Assessment (HTA) and reimbursement approvals. While the European Medicines Agency (EMA) oversees centralized drug approvals, pricing and reimbursement remain national decisions. Companies must navigate HAS clinical assessments, CEESP economic evaluations, and CEPS price negotiations to gain market access.

At Justin Stindt Consultants, we support companies with Pricing & Reimbursement strategies, HTA and JCA dossiers, and price negotiations to ensure a successful market entry in France. With the 2025 Health Technology Assessment Regulation introducing Joint Clinical Assessments (JCA), we stay ahead of regulatory developments to help you secure the best outcomes.

From early scientific advice to launch and price negotiations, we have a strong track record of helping clients achieve market success in France.

🔹 Need expert market access support in France? Contact Justin Stindt Consultants today to tailor a strategy for your success.

➡️   / justin-stindt-consulting  

#MarketAccess #HTA #PharmaConsulting #HealthcareFrance #France #JustinStindt #Biotech #Medtech #PharmaStrategy #PricingAndReimbursement #RegulatoryAffairs